May The Schwarz Be With You: UCB Proposes $5.6 Bil. Acquisition
Existing Schwarz deal with Pfizer unaffected by merger that would create a neurology heavyweight.
Existing Schwarz deal with Pfizer unaffected by merger that would create a neurology heavyweight.